|
Why BIOMatch ?
Nearly $60 million worth of deals negociated in
the 2005 edition!
- A unique event for venture capital, pharmaceutical, biotechnology
and health technology business leaders to interact;
- A place
for Canada’s life sciences companies to pursue business
and financing deals;
- An opportunity for biotechnology and
medical technology companies to showcase their products
to investors and pharmaceutical companies;
- In 2005, BIOMatch
gave the opportunity to participating businesses to negotiate
deals that are worth nearly $60 million.
How does one participate?
Open to:
- Biotechnology companies active in early pre-clinical
research stages;
- Biotechnology companies active in later
stages of development (phase III trial and marketing);
- Medical
technology companies.
| Confirmed
VCs and Investment Bankers for BIOMatch 2007: |
Confirmed
Life Sciences Companies for BIOMatch 2007: |
Canadian Medical Discoveries Fund Inc. (CMDF)
CDP Capital (Canada)
CTI Capital (Canada)
Desjardins Venture Capital (Canada)
Fonds BIOInnovation (Canada)
GeneChem (Canada)
Genesys Capital Partners Inc. (Canada)
Go Capital (Canada)
MDS Capital (Canada)
MMV Financial (Canada)
MSBi Capital (Canada)
National Bank of Canada (Canada)
Nexus Medical Partners (USA)
Pappas Ventures (Canada / USA)
ProQuest Ventures( Canada / USA)
RBC Technology Ventures (Canada)
Seaflower Ventures (USA)
Solidarity Fund, QFL (Canada)
T2C2 Capital (Canada)
TSX Ventures (Canada)
Ventures West Management (Canada)
Vimac Ventures LLC (Canada / USA) |
AstraZeneca (Canada)
Merck Frosst (Canada)
Novartis (Switzerland)
Pfizer (Canada)
Procter & Gamble (USA)
Shire Diagnostics (Canada)
Wyeth (USA) |
| VCs and Investment Bankers who attended BIOMatch
2006: |
Life
Sciences Companies who attended BIOMatch 2006: |
Banque Nationale du
Canada, Canada
BDC, Canada
Burrill & Company, Merchant Banking, USA
Canadian Medical Discoveries Fund, Canada
CDC Entreprises, France
CDP Capital, Canada
Desjardins Capital de risque, Canada
Fonds BIO-Innovation, Canada
Fonds de solidarité FTQ, Canada
Garage Technology Ventures, Canada / USA
GeneChem Management Inc., Canada
Genesys Capital, Canada
MDS Capital Corp., Canada
MMV Financial Inc., Canada
MSBi Capital, Canada
Nexus Medical Partners, USA
Northern Securities Inc., Canada
Pappas Ventures, USA
Paris & Partners, Italy
ProQuest Investments, USA
RBC Technology Ventures Inc., Canada
Seaflower Ventures, USA
SGF Soquia, Canada
T2C2/Bio, Canada
VantagePoint Venture Partners, USA
Ventures West, Canada
VIMAC Ventures LLC, USA |
3M Canada
AstraZeneca Canada Inc.
GE Healthcare
Genzyme Canada Inc.
GlaxoSmithKline Canada Inc.
Merck Frosst Canada Ltd.
Nicholas Piramal India Limited
Pfizer Canada
Purdue Pharma Inc.
Sanofi Pasteur Canada |
| |
|
BIOMatch 2007 program
| Thursday, March 29th, 2007 |
| 8:00 am - 9:00 am |
Registration |
| |
Track1 - BIOMatch |
| 9:00 am - 10:15 am |
Theme #1 – Financing life sciences businesses in 2007: challenges and successes.
Speakers:
- Simon Gill, Co-Head of Health Care Investment Banking, RBC Capital Market, Toronto, Canada.
- Minhas Mohamed, Chief Executive Officer, MMVF, Canada.
- Kelly Holman, Managing Director, Genesys Capital Partners Inc., Canada.
Moderator:
Presenting Companies:
- Resonant Medical
- Mimetogen
- Thallion Pharmaceuticals
|
| 10:45 am - 12:00 pm |
Theme #2 - Managing big pharma / big medical device partnerships.
Speakers:
- Jean-Marc Séquier, Global Business Development and Licensing, Head of Partnering / Out Licensing, Novartis, Switzerland.
Moderator:
- Pierre Cantin, Vice-president, Investments, Société générale de financement du Québec, Canada.
Presenting Companies:
- Methylgene
- Orthosoft
- Ambrilia Biopharma
|
| 12:00 pm - 1:45 pm |
Pharma Lunch (Panelists from Merck Canada, Wyett and Pfizer USA)
Moderators : Brenda H. Jarrell, Partner, Choate Hall & Stewart, USA.
Steven Hurwitz, Partner, Choate Hall & Stewart, USA. |
| 1:45 pm - 3:00 pm |
Theme #3 - Attracting, developing, evaluating and retaining human talent.
Speakers:
- Anita Graham, Executive Vice President, Global Human Resources, Shire Global, USA.
- Philippe Bourbonnais, Senior Client Partners, Korn/Ferry International, Canada.
Moderator:
Presenting Companies:
- Milestone Pharmaceuticals
- Innodia
- Tranzyme Pharma
- Cytochroma
|
| 3:15 pm - 4:30 pm |
Theme #4 - Generating awareness in life sciences.
Speakers:
- Marcia Kean, Chief Executive Officer, Feinstein Kean Healthcare (FKH), Boston, USA.
- Sophie Egholm, Associate Director, Strategic Alliances, Pfizer, USA.
Moderator:
- Patrice Roy, Regional Director, Research and Development, Pfizer, Canada.
Presenting Companies:
- Gemin X
- Royalmount Pharma
- RepliCor
- Genizon BioSciences
|
How does one register for BIOMatch 2007?
Investors >>
Download
the BIOMatch/VC registration form
Biotechnology and medical technology companies >>
Download
the registration form
Please note that every request submitted by a company who wishes to present at BIOMatch will be evaluated by a selection committee.
|
